| Product Candidates/Indications | Research | Pre-clinical | Phase 1 | Phase 2 |
|---|---|---|---|---|
| BNZ-1 (IL-2, IL-9, IL-15) | ||||
| T-cell Leukemia’s including Large Granular Leukemia (LGL) and Cutaneous T-cell Leukemia (CTCL) |
|
|||
| Alopecia Areata |
|
|||
| BNZ-2 (IL-15, IL-21) subcutaneous delivery | ||||
| Celiac Disease |
|
|||
| Inflammatory Bowel Disease (s.c.) |
|
|||
| BNZ-3 (IL-15, IL-21) oral delivery | ||||
| Celiac Disease |
|
|||
| Product Candidates/Indications | Phase | |
|---|---|---|
| BNZ-1 (IL-2, IL-15) | ||
| T-cell Leukemia’s including Large Granular Leukemia (LGL) and Cutaneous T-cell Leukemia (CTCL) |
Phase 2
|
|
| Alopecia Areata |
Phase 1 Completed
|
|
| BNZ-2 (IL-15, IL-21) subcutaneous delivery | ||
| Celiac Disease |
Pre-Clinical
|
|
| Inflammatory Bowel Disease (s.c.) |
Research
|
|
| BNZ-3 (IL-15, IL-21) oral delivery | ||
| Celiac Disease |
Research
|
|